UBA52P5

Across TCGA pan-cancer cohorts, UBA52P5 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated UBA52P5 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher UBA52P5 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated UBA52P5 expression acts as an unfavorable survival marker, although some lineages such as ESCA and SKCM show a favorable association.

MESO, STAD, and ACC are the cancer types where UBA52P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Median	All	0.458	0.622	<.001	74	view →
STAD	DFS	Median	III,IV	0.236	0.457	<.001	64	view →
ACC	OS	Median	All	0.460	0.769	.002	59	view →
ESCA	OS	Median	III,IV	0.659	0.426	.007	27	view →
SKCM	OS	Quartile	III,IV	0.486	0.223	.001	26	view →
HNSC	OS	Median	IV	0.509	0.302	.006	24	view →
DLBC	DFS	Median	IV	0.353	1.000	.013	18	view →
KIRP	OS	Median	All	0.565	0.782	.006	17	view →
SARC	OS	Median	All	0.660	0.857	.001	15	view →
LGG	OS	Tertile	All	0.871	0.958	.001	15	view →
CHOL	DFS	Quartile	II,III,IV	0.095	0.546	.024	6	view →
LIHC	OS	Tertile	II,III,IV	0.851	0.652	.018	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

UBA52P5–MESO (OS)

Open the MESO breakdown →